Patent · US Expired

Methods to identify immunomodulators using cognate interaction of PKC-theta

US6054286A · kind A · utility

3Cited by
8References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 15, 1999
Grant dateApr 25, 2000
Priority date
Expiry dateJan 15, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compounds having immunomodulating activity are identified using a methodology which employs TER14687, TER10311 and/or TER17210 as standards. The effect candidate compounds have on PKC-theta interaction with cognate binding proteins is measured and compared with the standards. The interaction can be measured by a variety of techniques, including assessing translocation of said PKC-theta or fragment. Kits containing the TER14687, TER10311 and/or TER17210 standards are disclosed. TER14687, TER10311 and/or TER17210 are useful in modulating the immune system in a subject by reducing T-cell activity. TER14687, TER10311, TER17210 are used as leads to develop other compounds having immunomodulating activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.